The present invention relates to devices, arrangements and methods involving body fluid acquisition. In certain embodiments, the present invention is directed to an interface member for contacting the skin of the user of a body fluid sampling device.
In this specification where a document, act or item of knowledge is referred to or discussed, this reference or discussion is not an admission that the document, act or item of knowledge or any combination thereof was at the priority date, publicly available, known to the public, part of common general knowledge, or otherwise constitutes prior art under the applicable statutory provisions; or is known to be relevant to an attempt to solve any problem with which this specification is concerned.
According to the American Diabetes Association, diabetes is the fifth-deadliest disease in the United States. Since 1987 the death rate due to diabetes has increased by 45 percent. There are an estimated 20.8 million children and adults in the United States, or 7% of the population, who have diabetes. The total annual economic cost of diabetes in 2007 was estimated to be $174 billion. This is an increase of $42 billion since 2002. This 32% increase means the dollar amount has risen over $8 billion each year.
A critical component in managing diabetes is frequent blood glucose monitoring. Currently, a number of systems exist for self-monitoring by the patient. Most fluid analysis systems, such as systems for analyzing a sample of blood for glucose content, comprise multiple separate components such as separate lancing, transport, and quantification portions. These systems are bulky, and often confusing and complicated for the user. The systems require significant user intervention.
Technology in the field of self-monitoring of blood glucose has placed the burden of acquiring sufficient blood for conducting a test on the user of the technology. Earlier versions of consumer-oriented self-monitoring products usually required many microliters of blood.
Lancing devices and the lancets themselves have also evolved somewhat over the past few decades. Some lancing mechanisms may produce relatively less pain by either (1) projecting the lancet in and out of the skin in a more straight path and thus reducing stimulation of percutaneous nerves which provide the pain stimulus; and (2) offering depth control in the lancing device so that the user may balance the expression of sufficient blood against the level of pain. Furthermore, lancet manufacturers offer a variety of lancet sizes, lengths, and tip bevel patterns with some companies claiming that their lancet is less painful than others.
What remains clear is that the most testers, when lancing at the finger, often must put down the lancing device after creating a wound and apply pressure near the finger tip in order to produce sufficient blood for the test strip in the meter. Many instructions for use of conventional meter systems specifically prescribe that the user perform this “milking” process because without it, many will not spontaneously produce the required volume. Applicants have observed this phenomenon in the use of commonly available commercial sampling and meter systems. In one study, when a trained professional lanced the finger tips of 16 volunteer diabetic subjects at the maximum depth setting on commercially available device under controlled conditions, only 15% of lanced sites spontaneously produced sufficient blood for the meter to accurately measure glucose levels.
Conventional sampling devices and methods are overly reliant upon user intervention, such as milking, in order to consistently express a sufficient quantity of blood from the wound site. Thus, it would be advantageous to provide constructions, arrangements and techniques that improved the ability to consistently and spontaneously obtain an adequate sample of body fluid from a sampling site on the skin of the user.
According to the present invention, there are provided constructions, arrangements and techniques that may address one or more of the above-mentioned objectives. However, the present invention is not limited to the context of blood sampling performed for the purposes of monitoring glucose concentration. Numerous alternative applications or uses for the concepts described herein are contemplated.
According to certain aspects of the present invention, there are provided constructions, arrangements and techniques that may optionally provide one or more of the following benefits or advantages: increase in the likelihood of a spontaneous production of blood from a wound created by a skin-penetrating member; providing the user with a tactile and visual aid for correctly positioning the device or arrangement; creating a sufficient seal between the skin at the sampling site and one or more components of the arrangement; and reduction or mitigation of pain sensation.
As used herein “digital” means fingers or toes. “Digital body fluid” means expression of body fluid from a wound created on the fingers or toes, and encompasses lancing sites on the dorsal or palm side of the distal finger tips.
As used herein, “body fluid” encompasses whole blood, intestinal fluid, and mixtures thereof.
As used herein “integrated device” or “integrated meter” means a device or meter that includes all components necessary to perform sampling of body fluid, transport of body fluid, quantification of an analyte, and display of the amount of analyte contained in the sample of body fluid.
It is to be understood that reference herein to first, second, third and fourth components (etc.) does not limit the present invention to embodiments where each of these components is physically separable from one another. For example, a single physical element of the invention may perform the functions of more than one of the claimed first, second, third or fourth components. Conversely, a plurality of separate physical elements working together may perform the functions of one of the claimed first, second, third or fourth components. Similarly, reference to first, second (etc.) method steps does not limit the invention to only separate steps. According to the invention, a single method step may satisfy multiple steps described herein. Conversely, a plurality of method steps could, in combination, constitute a single method step recited herein. In addition, the steps of the method are not necessarily limited to the order in which they are described or claimed herein.
According to one aspect, the present invention is directed to an arrangement for producing a sample of body fluid from a wound opening created in a skin surface at a sampling site, the arrangement comprising: a housing, the housing comprising a first opening; a skin interface member disposed in the first opening, the skin interface member comprising an inner member having a second opening, and an outer member at least partially surrounding the inner member and attached to the first opening; and at least one skin-penetration member configured and arranged to project within the second opening.
According to another aspect, the present invention is directed to an arrangement for producing a sample of body fluid from a wound opening created in a skin surface at a sampling site, the arrangement comprising: a housing, the housing comprising a first opening; a skin interface member disposed in the first opening, the skin interface member comprising an inner portion having a second opening, the inner portion further comprising a first projection along the second opening and a second projection along the second opening, the first and second projections extending in opposite directions, and the skin interface member further comprising an outer portion at least partially surrounding the inner portion and attached to the first opening; at least one skin-penetration member configured and arranged to project within the second opening; a cartridge disposed within the housing, wherein the at least one skin-penetration member is disposed within the cartridge.
According to a further aspect, the present invention provides an arrangement for producing a sample of body fluid from a wound opening created in a skin surface at a sampling site, the arrangement comprising: a housing, the housing comprising a first opening; a skin interface member disposed in the second opening, the skin interface member comprising a longitudinally tapered cylindrical member having a first opening constructed an arranged to be contacted by the skin, the inner diameter of the cylinder decreasing along the longitudinal direction away from the second opening, the longitudinally tapered cylindrical member comprising a plurality of longitudinal slits thereby forming a plurality of longitudinal sections, the longitudinally tapered cylindrical member constructed and arranged so as to be movable within the first opening upon pressing against the surface of the skin at the second opening thereby forcing the longitudinal sections radially inward; and at least one skin-penetration member configured and arranged to project within the second opening.
According to yet another aspect, the present invention provides an arrangement for producing a sample of body fluid from a wound opening created in a skin surface at a sampling site, the arrangement comprising: a housing, the housing comprising a first opening; a skin interface member disposed in the first opening, the skin interface member comprising a plurality of concentric telescoping sections, including an innermost section, the innermost section having a second opening, the innermost member constructed and arranged so as to be pressed against the surface of the skin at the second opening; and at least one skin-penetration member configured and arranged to project within the second opening.
According to an additional aspect, the present invention provides an arrangement for producing a sample of body fluid from a wound opening created in a skin surface at a sampling site, the arrangement comprising: a housing, the housing comprising a first opening; a skin interface member disposed in the first opening, the skin interface member comprising a plurality of rotatable members defining a gap therebetween, the plurality of rotatable members constructed an arranged such that rotatable members are forced toward one another upon being pressed against the skin thereby decreasing the gap and pinching the skin; and at least one skin-penetration member configured and arranged to project within the gap.
The following description of preferred embodiments can be read in connection with the accompanying drawings in which like numerals designate like elements and in which:
According to a first aspect of the present invention, there are provided arrangements and techniques for reliably expressing body fluid from a digit or from an alternate site such as the forearm, thigh, etc. For example, according to the present invention, arrangements and techniques are provided which consistently and reliably express an amount of body fluid that is sufficient to perform an analysis to quantify the amount of an analyte (e.g., glucose, bilirubin, alcohol, controlled substances, toxins, hormones, proteins, etc.) contained therein.
One embodiment of an arrangement 10 of the type described above is illustrated in
The arrangements described herein may be used or applied to a skin surface 12 at a suitable sampling site 14. One suitable sampling site 14 is on a digit D. However, the arrangements described herein may be used or applied to any skin surface at any suitable sampling site which may include alternative sampling sites such as the forearm, thigh, etc.
According to the illustrated embodiment, the arrangement 10 includes a housing 16. The housing 16 may have any suitable shape or configuration, and is not limited to the shape and configuration illustrated. According to one alternative construction, the housing 16 may comprise at least a portion of a removable cap (not shown). The shape of the housing 16 may be contoured such that it is easily grasped by the hand of the user. The housing 16 can be constructed of any suitable material. For example, the housing 16 may be constructed of a polymeric or metallic material. The housing may comprise a first opening 18 disposed therein. A skin interface member 20 constructed according to the principles of the present invention may be disposed in the first opening 18 and provided with an attachment 22 to the housing 16. According to one embodiment, the attachment 22 is readily removable from the opening 18 in the housing 16, thereby allowing the user to remove an existing skin interface member 20 and insert a replacement or alternatively constructed skin interface members 20.
As illustrated in
The arrangements described herein may further optionally include a catalyst to assist in the sample acquisition process by enhancing or facilitating perfusion of body fluid at a sampling site. At least one of several catalysts may be utilized or included in the arrangement of the present invention. Possible catalysts include, heat, pressure, vacuum, vibration, and topical drugs (which induce vasodilatation and increases the blood or body fluid available at the lancing site). These catalysts may be applied before, during, after lancing, or in combination with some or all three, to facilitate expression of sufficient quantity of body fluid for determination of the concentration of an analyte contained therein (e.g., glucose).
Skin interface member contact pressure is another catalyst and can be varied by a number of possible techniques. One such technique is to vary the size of an opening of the skin interface member. Another form of pressure catalyst can take the form of a squeezing or pinching member(s), as illustrated by examples which will be described herein.
Heat is another optional catalyst. Applying heat, thereby increasing the skin temperature at the wound site, increases blood production. Possible implementations of heat include infrared (IR) lights, or resistive elements to heat the skin.
Another catalyst is vacuum pressure. According to certain embodiments, a light vacuum (e.g., 3-8 in. Hg) is applied to surface of the skin 12 at the sampling site 14 before, during, and/or after lancing. Several embodiments for applying vacuum to the wound site are contemplated. One embodiment uses a motor driven pump 23 (
According to the principles of the present invention, one or more of the above-described catalysts can be used in combination with each other, either concurrently or sequentially.
A skin interface member 20 may take any suitable form. For example, according to the illustrated embodiment, the skin interface member 20 comprises an outer member 24, which may include the aforementioned attachment structure 22 that affixes the skin interface member 20 to the housing, and an inner member 26. The inner member 26 comprises a second opening 28. The second opening 28 can take any suitable size and/or geometry. For example, the second opening 28 can be substantially circular or ovular, and have a diameter of about 3 mm-8 mm. According to a further alternative embodiment, the second opening 28 has a diameter of about 6 mm. The outer member 24 at least partially surrounds the inner member 26 and is attached thereto. Any suitable form of attachment is contemplated. For example, the outer member 24 and inner member 26 may be connected via an adhesive, or maybe integrated together via a co-molding process or similar integration technique. According to one embodiment, the inner member 26 has a first hardness, and the outer member 24 has a second hardness, wherein the first hardness is greater than the second hardness. The inner and outer members 26, 24 can be formed from any suitable materials. For example, the outer member 24 can be formed from an elastomer, silicone rubber, or soft plastic. The inner member 26 may be formed from a metal, plastic, relatively hard elastomer or ceramic.
Applicants have discovered that by providing the skin interface member 20 with a relatively harder inner member 26, a number of advantages are obtained. For instance, it has been observed that a skin interface member having a relatively harder inner member forms a better more reliable seal with the surface of the skin compared to a skin interface member formed entirely from a relatively soft pliable material. It has also been observed that many users prefer the tactile feel of the relatively hard inner member 26 when applied to the surface of the skin. This improved tactile feel also facilitates the correct positioning of the skin interface member for body fluid sampling.
The arrangements described herein may have a number of additional optional features. For example, at least one of the outer or inner members 24, 26 may have a construction so as to emit visible light thereby facilitating use of the arrangements in low-light conditions. Alternatively, the housing 16 may be provided with such a mechanism for emitting visible light. Optionally, the area of the housing in proximity to skin interface member 20 may be provided with the aforementioned light-emitting mechanism. Any number of mechanisms that emit visible light can be provided. For example, a potion of the housing 16 or at least one of the outer or inner members 24, 26 may be formed from a fluorescent material. Alternatively, one or more light emitting elements, such as light emitting diodes, schematically illustrated as elements 30 and 30′, can be mounted within at least one of the housing 16 or outer and inner members 24, 26.
One or more members for generating heat may be incorporated into the skin interface member 20 of the present invention. Thus, for example, resistive heating elements, also generically illustrated as element 30, may be embedded within at least one of the outer and inner members 24, 26.
At least one of the outer and inner members 24, 26 may be provided with a textured surface for improving the tactile feel when applied to the skin of the user.
At least one sensor, generically illustrated as element 31, may also be provided for detecting contact with the skin of the user, and/or the amount of pressure exerted between the skin and the interface member 20 and/or the arrangement 10. Thus, for example, based on information derived from the sensor 31, the arrangement 10 can provide audible and/or visible feedback to the user to indicate when a target or optimal pressure is being applied to the skin 12 at the sampling site 14, and/or when the pressure being applied by the user lies outside of the target pressure value or range. Moreover, the arrangement 10 can be configured to use information derived from the sensor 31 to initiate one or more functions or operations. For example, an automated test sequence can be initiated once a minimum amount of force is sensed between the skin and the interface member 20, or if contact with the skin is sensed for a predetermined period of time. According to a further alternative embodiment, if no contact with the skin is sensed, the arrangement may automatically initiate a stand-by or shut down mode.
Optionally, if no contact with the skin is sensed, the arrangement may automatically cover or close the second opening 28, so as to shield the inside of the arrangement 10 from the external environment and/or ambient light. The sensor can be located in any suitable portion of the arrangement, such as in the outer or inner member 24, 26, and/or the housing 16. The at least one sensor 31 can comprise, for example, well-known pressure transducer technology, capacitive touch sensing technology, resistive touch sensing technology, simple dome switch, or other micro switch, and the arrangement may further comprise additional signal processing and control components that are conventional in the art.
According to a further optional aspect, at least the inner member 26 of the skin interface member 20 can be provided with a hydrophobic property. This can be accomplished by forming the inner member entirely of a hydrophobic material, or by providing a hydrophobic coating onto one or more surfaces of the inner member 26. By providing the inner member 26 with a hydrophobic property, any body fluid coming into contact with the hydrophobic material of inner member skin interface member 20 will be repelled, preferably in a direction that leads it toward the inside of the housing 16, or it may be collected for performing an assay. According to a further optional construction, the skin penetration member (e.g., 34,
An additional optional feature of the arrangement 10 includes a cartridge 32. The cartridge 32 may include one or more components which are utilized to collect, transport, and perform an assay on a sample of body fluid, as will be described in more detail below. When the arrangement 10 includes such a cartridge 32, the skin interface member 20 may be provided with at least one contoured surface 33 which is intended to form a seal when pressed against the cartridge 32. The seal formed by the surface 33 against the cartridge 32 may optionally be substantially vacuum-tight. Thus, when vacuum is utilized as an optional catalyst, the seal formed by the surface 33 pressing against the cartridge 32 allows for the creation of a vacuum in the area of the skin 12 at the sampling site 14.
The arrangement 10 may further includes at least one skin penetration member 34. The at least one skin penetration member 34 can take any suitable form. For example, the at least one skin penetration member can comprise a solid lancet or a hollow needle. Conventional arrangements often require separate mechanisms for drawing a sample of blood to the surface of the skin and for transporting the sample to a reaction chamber. The arrangements of the present invention can optionally include a skin-piercing element in the form of a hollow needle to both create a wound opening and transport the sample, thereby greatly simplifying and improving the effectiveness of the arrangement 10.
According to one optional embodiment, the skin-penetration member(s) 34 can be in the form of a so-called “microneedle.” As the name implies, microneedles are characterizable by their relatively small outer diameters. For example, a microneedle, as the term is utilized herein, may encompass a skin-penetration member having an outside diameter which is on the order of 40-200 μm. When the microneedle is hollow and comprises an inner lumen, the inside diameter can vary, for example, having an inside diameter on the order of 25-160 μm. Needles are also characterizable in the art by reference to the “gage.” By way of illustration, and consistent with the above description, microneedles having a gage ranging from 26-36 are clearly comprehended by the present invention. Certain advantages may be gleaned from the use of such microneedles as the skin-penetration member. In particular, due to their small size, the size of the wound left upon entry into the skin is relatively small, thereby minimizing the pain associated with such needle insertions and allowing for a quicker healing process. However, the present invention is certainly not limited to the use of such microneedles. Thus, for example, according to one possible alternative embodiment, the skin penetration member(s) comprise hollow needles having a gage of about 20-25, or comprising hollow needles having an inner diameter of about 0.007 inches and an outer diameter of about 0.020 inches.
The at least one skin-penetration member 34 can be formed of any suitable material, such as metal, plastic, glass, etc. Optionally, the at least one skin penetration member can be in communication with an analyte quantification member 36. In further alternative embodiments, the analyte quantification member 36 may include an assay pad 38 comprising a reagent that changes color upon reaction with a target analyte, as known per se to those skilled in the art. The assay pad 38 is in fluid communication with the sample of body fluid. The assay pad 38 can be analyzed by a detector 42, such as an optical sensor, that forms part of the arrangement 10. Alternatively, the assay pad 38 can be removed from the arrangement 10 and inserted into a separate device, such as an electrochemical or photometric meter.
The at least one skin penetration member 34, and/or the analyte quantification member 36 may optionally be attached to an actuation element 40. The actuation element 40 can take any suitable form. For example, the actuation element 40 may comprise a mechanical, electrical or pneumatic element. According to the illustrated embodiment, the actuation element 40 is in the form of a mechanical spring. The actuation element 40 drives the at least one skin-penetration member 34 into the skin 12 at the sampling site 14, as indicated by the broken line outline of the skin-penetration member 34 as illustrated in
As further illustrated in
According to certain embodiments of the present invention, the arrangement 10, or integrated meter 11, can operate in an automatic or semi-automatic manner. For example, a user may place the skin interface member 20 over the surface of the skin 12 and when the user is ready to produce a sample of body fluid and/or perform an assay, the user initiates the process by, for example, pressing a button, touch screen, or other device interface (not shown). This can initiate a programmed sequence of events in the arrangement or integrated meter which may include one or more of actuation of a catalyst, and driving the skin-penetration member 34 into the skin. At a predetermined time, the catalyst device 14 is deactivated. This mode of operation can be characterized as “semi-automatic” in that sequence of events is manually initiated by the user.
According to one alternative, the mode of operation can be fully automatic. For example, the user places the skin interface member 20 over the skin 12 at a suitable sampling site. The arrangement 10, or integrated meter 11, can be provided with one or more sensors, such as sensors generically illustrated as element 31, that detect and verify that the skin interface member is properly located and ready for the sampling procedure to begin. Once this state has been sensed, the device automatically activates a programmed sequence of events in the device which may include one or more of activation of a catalyst, and driving the skin-penetration member 34 into the skin. At a subsequent predetermined time, the catalyst device 14 is deactivated. The catalyst device can be deactivated before, during or after the skin-piercing member is driven into the skin.
The skin interface member 20 may be provided with a suitable construction so as to provide an adjustable mechanism for altering the above-mentioned separation distance between the housing and the surface of the skin. An illustrative example of one such arrangement 10′ is contained in
Conversely, as illustrated in
According to a further alternative construction of the present invention, a further modified arrangement 10″ can be provided along the lines of the arrangement illustrated in
Additional alternative constructions for arrangements and/or skin interface members will now be described. However, it should be understood that any of the skin interface member embodiments described below can be utilized in conjunction with an arrangement including any combination of features of the arrangements described herein. The same reference numerals used above will also be used to describe corresponding features in the description of the following embodiments.
An alternative arrangement 100 constructed according to the principles of the present invention is illustrated in
An arrangement 200 formed according to a further alternative arrangement of the present invention is illustrated in
Yet another arrangement 400 formed according to the principles of the present invention is illustrated in
The stimulus or mechanism for effecting the change in diameter can be initiated manually by a user, or automatically by an associated device. For example, a user can select an appropriate interface mechanism to initiate a single reduction in diameter, or to initiate a cycle of changes in diameter between a larger diameter opening (D1) and a smaller diameter opening (D2). Alternatively, the stimulus or mechanism for effecting change in diameter can be automatically initiated by an associated device such as an arrangement or integrated meter as described herein. For example, the device may be provided with one or more sensors, such as those previously described herein, which are capable of sensing contact of the device with the surface of the skin of a user, and/or a pressure associated therewith. According to one alternative embodiment, if the device fails to detect contact with the skin, an appropriate stimulus, such as an electrical current, can be automatically generated by the device and applied to a shape memory material forming the inner member 626 thereby causing an appropriate reduction in diameter. Thus, the device may automatically enter a shutdown or standby mode wherein the diameter (D2) of the opening of the inner member 626 is reduced to such an extent that it entirely closes, or substantially closes, the opening in the inner member 626, thereby shielding the inside of the device from the external environment and/or ambient light (e.g.,
As noted above, a number of alternative mechanisms are contemplated for providing the desired change in diameter of the inner member of the skin interface member 620. One such alternative is illustrated in
Another alternative mechanism is illustrated in
An exemplary body fluid sampling method or technique which may be used in conjunction with any of the above-described arrangements, but is not necessarily limited thereto, is described as follows.
A skin interface member is placed on the skin over a sampling site located on a digit or at an alternate site. The skin interface member has an opening therein which corresponds to the sampling site. The skin interface member is provided with a construction that aids or facilitates the perfusion of blood at the sampling site, such as any of the skin interface member constructions described herein, in order to improve the probability of a spontaneous expression of blood upon wound creation. A sequence of events is then initiated. The events can be initiated manually, for example, by pressing a button or other triggering mechanism. Alternatively, the events can be automatically triggered, for example, through the use of one or more sensors which determine when the skin interface member has been properly positioned over a sampling site on the surface of the skin. A catalyst is then optionally applied to the sampling site. The catalyst can comprise one or more of heat, pressure, vacuum, vibration, topical drugs, squeezing or combinations thereof. These catalysts can be applied concurrently or sequentially relative to one another. According to one embodiment, a catalyst in the form of vacuum pressure is applied to the sampling site via a suitable mechanism, such as a pump capable of creating vacuum pressure. The catalyst can be applied for a set period of time, and then removed or terminated. For example, the catalyst can be removed before, during, or after penetration of the skin. Next, at least one skin penetration member is actuated or driven into the surface of the skin. The skin penetration member can take any suitable form, such as a solid lancet or hollow needle (e.g., a microneedle). According to one embodiment, the at least one skin penetration member comprises a hollow needle having a first end configured to pierce the surface of the skin, and an inner lumen. The at least one skin penetration member can be actuated via any suitable mechanism, such as a mechanical spring. According to one embodiment, body fluid is transported away from the wound site via a suitable mechanism. According to one embodiment, the body fluid, or blood, is transported via the inner lumen of a hollow skin-penetration member via capillary action, vacuum, or a combination of both. The body fluid can be transported to an analyte quantification member of any suitable construction. According to one embodiment, the analyte quantification member comprises an assay pad which contains a chemical reagent impregnated therein. Upon exposure to the body fluid, a target analyte contained therein causes a chemical reaction with the reagent producing a color change in the assay pad. This color change can in turn be detected by a suitable detection element. One such detection element comprises an optical sensor.
Numbers expressing quantities of ingredients, constituents, reaction conditions, and so forth used in this specification are to be understood as being modified in all instances by the term “about”. Notwithstanding that the numerical ranges and parameters setting forth, the broad scope of the subject matter presented herein are approximations, the numerical values set forth are indicated as precisely as possible. Any numerical value, however, inherently contains certain errors necessarily resulting from the standard deviation found in their respective measurement techniques. None of the elements recited in the appended claims should be interpreted as invoking 35 U.S.C. §112, ¶6, unless the term “means” is explicitly used.
Although the present invention has been described in connection with preferred embodiments thereof, it will be appreciated by those skilled in the art that additions, deletions, modifications, and substitutions not specifically described may be made without departing from the spirit and scope of the invention as defined in the appended claims.
This application claims priority to U.S. Provisional Patent Application No. 61/129,025, filed on May 28, 2008.
Number | Name | Date | Kind |
---|---|---|---|
842690 | Oswalt | Jan 1907 | A |
D137874 | Partridge | May 1944 | S |
2749797 | Harks | Mar 1950 | A |
3092465 | Adams, Jr. | Jun 1963 | A |
3310002 | Wilburn | Mar 1967 | A |
3620209 | Kravitz | Nov 1971 | A |
3623475 | Sanz et al. | Nov 1971 | A |
3626929 | Sanz et al. | Dec 1971 | A |
3630957 | Rey | Dec 1971 | A |
D223165 | Komendat | Mar 1972 | S |
3723064 | Liotta | Mar 1973 | A |
3741197 | Sanz et al. | Jun 1973 | A |
3961898 | Neeley et al. | Jun 1976 | A |
3992158 | Przybylowicz et al. | Nov 1976 | A |
4014328 | Cluff et al. | Mar 1977 | A |
4042335 | Clement | Aug 1977 | A |
4057394 | Genshaw | Nov 1977 | A |
4109655 | Chacornac | Aug 1978 | A |
4253083 | Imamura | Feb 1981 | A |
4254083 | Columbus | Mar 1981 | A |
4258001 | Pierce et al. | Mar 1981 | A |
4260257 | Neeley et al. | Apr 1981 | A |
4289459 | Neeley et al. | Sep 1981 | A |
4321397 | Nix et al. | Mar 1982 | A |
4350762 | DeLuca et al. | Sep 1982 | A |
4394512 | Batz | Jul 1983 | A |
4414975 | Ryder et al. | Nov 1983 | A |
4416279 | Lindner et al. | Nov 1983 | A |
4418037 | Katsuyama et al. | Nov 1983 | A |
4422941 | Vaughan, Jr. et al. | Dec 1983 | A |
4429700 | Thees et al. | Feb 1984 | A |
4627445 | Garcia et al. | Dec 1986 | A |
4637403 | Garcia et al. | Jan 1987 | A |
4637406 | Guinn et al. | Jan 1987 | A |
4653513 | Dombrowski | Mar 1987 | A |
4661319 | Lape | Apr 1987 | A |
4702261 | Cornell et al. | Oct 1987 | A |
4711250 | Gilbaugh, Jr. et al. | Dec 1987 | A |
4737458 | Batz et al. | Apr 1988 | A |
4767415 | Duffy | Aug 1988 | A |
4774192 | Terminiello et al. | Sep 1988 | A |
4790979 | Terminiello et al. | Dec 1988 | A |
4794926 | Munsch et al. | Jan 1989 | A |
4815843 | Tiefenthaler et al. | Mar 1989 | A |
4829470 | Wang | May 1989 | A |
4844095 | Chiodo et al. | Jul 1989 | A |
4846785 | Cassou et al. | Jul 1989 | A |
4887306 | Hwang et al. | Dec 1989 | A |
4920977 | Haynes | May 1990 | A |
4929426 | Bodai et al. | May 1990 | A |
4930525 | Palestrant | Jun 1990 | A |
4935346 | Phillips | Jun 1990 | A |
4953552 | De Marzo | Sep 1990 | A |
4966646 | Zdeblick | Oct 1990 | A |
4983178 | Schnell | Jan 1991 | A |
4995402 | Smith | Feb 1991 | A |
5026388 | Ingalz | Jun 1991 | A |
5029583 | Meserol | Jul 1991 | A |
5035704 | Lambert et al. | Jul 1991 | A |
5049487 | Phillips et al. | Sep 1991 | A |
5050617 | Columbus et al. | Sep 1991 | A |
5059394 | Phillips et al. | Oct 1991 | A |
5077199 | Basagni et al. | Dec 1991 | A |
5094943 | Siedel et al. | Mar 1992 | A |
5110724 | Hewett | May 1992 | A |
5114350 | Hewett | May 1992 | A |
5116759 | Klainer et al. | May 1992 | A |
5131404 | Neeley et al. | Jul 1992 | A |
5141868 | Shanks et al. | Aug 1992 | A |
5145565 | Kater et al. | Sep 1992 | A |
5146437 | Boucheron | Sep 1992 | A |
5153416 | Neeley | Oct 1992 | A |
5164575 | Neeley et al. | Nov 1992 | A |
5166498 | Neeley | Nov 1992 | A |
5174291 | Schoonen et al. | Dec 1992 | A |
5176632 | Bernardi | Jan 1993 | A |
5179005 | Phillips et al. | Jan 1993 | A |
5183741 | Arai et al. | Feb 1993 | A |
5196302 | Kidwell | Mar 1993 | A |
5208163 | Charlton et al. | May 1993 | A |
5213966 | Vuorinen et al. | May 1993 | A |
5217480 | Habar et al. | Jun 1993 | A |
5218966 | Yamasawa | Jun 1993 | A |
5223219 | Subramanian et al. | Jun 1993 | A |
5228972 | Osaka et al. | Jul 1993 | A |
5234818 | Zimmermann et al. | Aug 1993 | A |
5241969 | Carson et al. | Sep 1993 | A |
5251126 | Kahn et al. | Oct 1993 | A |
D341848 | Bigelow et al. | Nov 1993 | S |
5269800 | Davis, Jr. | Dec 1993 | A |
5275159 | Grieble | Jan 1994 | A |
5278079 | Gubinski et al. | Jan 1994 | A |
5279294 | Anderson et al. | Jan 1994 | A |
5288646 | Lundsgaard et al. | Feb 1994 | A |
5299571 | Mastrototaro | Apr 1994 | A |
5301686 | Newman | Apr 1994 | A |
5302513 | Mike et al. | Apr 1994 | A |
5304468 | Phillips et al. | Apr 1994 | A |
5306623 | Kiser et al. | Apr 1994 | A |
5308767 | Terashima | May 1994 | A |
5314441 | Cusack et al. | May 1994 | A |
5320607 | Ishibashi | Jun 1994 | A |
5354537 | Moreno | Oct 1994 | A |
5360595 | Bell et al. | Nov 1994 | A |
5368047 | Suzuki et al. | Nov 1994 | A |
5383512 | Jarvis | Jan 1995 | A |
5390671 | Lord et al. | Feb 1995 | A |
5395388 | Schraga | Mar 1995 | A |
5399316 | Yamada | Mar 1995 | A |
5401110 | Neeley | Mar 1995 | A |
5402798 | Swierczek et al. | Apr 1995 | A |
5426032 | Phillips et al. | Jun 1995 | A |
5441513 | Roth | Aug 1995 | A |
5451350 | Macho et al. | Sep 1995 | A |
5458140 | Eppstein et al. | Oct 1995 | A |
5460777 | Kitajima et al. | Oct 1995 | A |
5460968 | Yoshida et al. | Oct 1995 | A |
5482473 | Lord et al. | Jan 1996 | A |
5506200 | Hirschkoff et al. | Apr 1996 | A |
5507288 | Böcker et al. | Apr 1996 | A |
5508200 | Tiffany et al. | Apr 1996 | A |
5510266 | Bonner et al. | Apr 1996 | A |
5514152 | Smith | May 1996 | A |
5525518 | Lundsgaard et al. | Jun 1996 | A |
5563042 | Phillips et al. | Oct 1996 | A |
5568806 | Cheney, II et al. | Oct 1996 | A |
5569287 | Tezuka et al. | Oct 1996 | A |
5575403 | Charlton et al. | Nov 1996 | A |
5577499 | Teves | Nov 1996 | A |
5578014 | Erez et al. | Nov 1996 | A |
5582184 | Erickson et al. | Dec 1996 | A |
5586553 | Halili et al. | Dec 1996 | A |
5591139 | Lin et al. | Jan 1997 | A |
5593838 | Zanzucchi et al. | Jan 1997 | A |
5611809 | Marshall et al. | Mar 1997 | A |
5624458 | Lipscher | Apr 1997 | A |
5630986 | Charlton et al. | May 1997 | A |
5632410 | Moulton et al. | May 1997 | A |
5636632 | Bommannan et al. | Jun 1997 | A |
5647851 | Pokras | Jul 1997 | A |
5658515 | Lee et al. | Aug 1997 | A |
5660791 | Brenneman et al. | Aug 1997 | A |
5670031 | Hintsche et al. | Sep 1997 | A |
5676850 | Reed et al. | Oct 1997 | A |
5680858 | Hansen et al. | Oct 1997 | A |
5681484 | Zanzucchi et al. | Oct 1997 | A |
5682233 | Brinda | Oct 1997 | A |
5697901 | Eriksson | Dec 1997 | A |
5700695 | Yassinzadeh et al. | Dec 1997 | A |
5701181 | Boiarski et al. | Dec 1997 | A |
5701910 | Powles et al. | Dec 1997 | A |
D389761 | Thomas | Jan 1998 | S |
5705018 | Hartley | Jan 1998 | A |
5708787 | Nakano et al. | Jan 1998 | A |
5715417 | Gardien et al. | Feb 1998 | A |
5730753 | Morita | Mar 1998 | A |
5735273 | Kurnik et al. | Apr 1998 | A |
5736103 | Pugh | Apr 1998 | A |
5741211 | Renirie et al. | Apr 1998 | A |
5746217 | Erickson et al. | May 1998 | A |
5746720 | Stouder, Jr. | May 1998 | A |
5757666 | Schreiber et al. | May 1998 | A |
5759364 | Charlton et al. | Jun 1998 | A |
5766066 | Ranniger | Jun 1998 | A |
5771890 | Tamada | Jun 1998 | A |
5797693 | Jaeger | Aug 1998 | A |
5800420 | Gross et al. | Sep 1998 | A |
5801057 | Smart et al. | Sep 1998 | A |
5807375 | Gross et al. | Sep 1998 | A |
5820570 | Erickson et al. | Oct 1998 | A |
5827183 | Kurnik et al. | Oct 1998 | A |
5840020 | Heinonen et al. | Nov 1998 | A |
5841126 | Fossum et al. | Nov 1998 | A |
5843692 | Phillips et al. | Dec 1998 | A |
5846837 | Thym et al. | Dec 1998 | A |
5851215 | Mawhirt et al. | Dec 1998 | A |
5854074 | Charlton et al. | Dec 1998 | A |
D403975 | Douglas et al. | Jan 1999 | S |
5855801 | Lin et al. | Jan 1999 | A |
5856195 | Charlton et al. | Jan 1999 | A |
5858194 | Bell | Jan 1999 | A |
5866281 | Guckel et al. | Feb 1999 | A |
5871494 | Simons et al. | Feb 1999 | A |
5879310 | Sopp et al. | Mar 1999 | A |
5879326 | Godshall et al. | Mar 1999 | A |
5879367 | Latterell et al. | Mar 1999 | A |
5885839 | Lingane et al. | Mar 1999 | A |
5891053 | Sesekura | Apr 1999 | A |
5893870 | Talen et al. | Apr 1999 | A |
D411621 | Eisenbarth et al. | Jun 1999 | S |
5911711 | Pelkey | Jun 1999 | A |
5911737 | Lee et al. | Jun 1999 | A |
5912139 | Iwata et al. | Jun 1999 | A |
5925021 | Castellano et al. | Jul 1999 | A |
5928207 | Pisano et al. | Jul 1999 | A |
5930873 | Wyser | Aug 1999 | A |
5938679 | Freeman et al. | Aug 1999 | A |
5945678 | Yanagisawa | Aug 1999 | A |
5951492 | Douglas et al. | Sep 1999 | A |
5951493 | Douglas et al. | Sep 1999 | A |
5954685 | Tierney | Sep 1999 | A |
5962215 | Douglas et al. | Oct 1999 | A |
5968760 | Phillips et al. | Oct 1999 | A |
5968765 | Grage et al. | Oct 1999 | A |
5968836 | Matzinger et al. | Oct 1999 | A |
5971941 | Simons | Oct 1999 | A |
5972294 | Smith et al. | Oct 1999 | A |
5986754 | Harding | Nov 1999 | A |
5989409 | Kurnik et al. | Nov 1999 | A |
5993189 | Mueller et al. | Nov 1999 | A |
6001067 | Shults et al. | Dec 1999 | A |
6005545 | Nishida et al. | Dec 1999 | A |
6010463 | Lauks et al. | Jan 2000 | A |
6010519 | Mawhirt et al. | Jan 2000 | A |
6014135 | Fernandes | Jan 2000 | A |
6014577 | Henning et al. | Jan 2000 | A |
6023629 | Tamada | Feb 2000 | A |
6027459 | Shain | Feb 2000 | A |
6030827 | Davis et al. | Feb 2000 | A |
6032059 | Henning et al. | Feb 2000 | A |
6036924 | Simons et al. | Mar 2000 | A |
6041253 | Kost et al. | Mar 2000 | A |
6050988 | Zuck | Apr 2000 | A |
6056701 | Duchon et al. | May 2000 | A |
6056734 | Jacobsen et al. | May 2000 | A |
6058321 | Swayze et al. | May 2000 | A |
6059815 | Lee et al. | May 2000 | A |
6061128 | Zweig et al. | May 2000 | A |
6063039 | Cunningham et al. | May 2000 | A |
6071251 | Cunningham et al. | Jun 2000 | A |
6071294 | Simons et al. | Jun 2000 | A |
6077660 | Wong et al. | Jun 2000 | A |
6080116 | Erickson et al. | Jun 2000 | A |
6083196 | Trautman et al. | Jul 2000 | A |
6086544 | Hibner et al. | Jul 2000 | A |
6090790 | Eriksson | Jul 2000 | A |
6091975 | Daddona et al. | Jul 2000 | A |
6093156 | Cunningham et al. | Jul 2000 | A |
6097831 | Wieck et al. | Aug 2000 | A |
6099484 | Douglas et al. | Aug 2000 | A |
6100107 | Lei et al. | Aug 2000 | A |
6102933 | Lee et al. | Aug 2000 | A |
6103033 | Say et al. | Aug 2000 | A |
6103197 | Werner | Aug 2000 | A |
6106751 | Talbot et al. | Aug 2000 | A |
6118126 | Zanzucchi | Sep 2000 | A |
6120676 | Heller et al. | Sep 2000 | A |
6123861 | Santini, Jr. et al. | Sep 2000 | A |
6126899 | Woudenberg et al. | Oct 2000 | A |
6132449 | Lum et al. | Oct 2000 | A |
6139562 | Mauze et al. | Oct 2000 | A |
6142939 | Eppstein et al. | Nov 2000 | A |
6152942 | Brenneman et al. | Nov 2000 | A |
6162639 | Douglas | Dec 2000 | A |
6172743 | Kley et al. | Jan 2001 | B1 |
6175752 | Say et al. | Jan 2001 | B1 |
6176865 | Mauze et al. | Jan 2001 | B1 |
6183434 | Eppstein et al | Feb 2001 | B1 |
6183489 | Douglas et al. | Feb 2001 | B1 |
6187210 | Lebouiz et al. | Feb 2001 | B1 |
6192891 | Gravel et al. | Feb 2001 | B1 |
6193873 | Ohara et al. | Feb 2001 | B1 |
6200296 | Dibiasi et al. | Mar 2001 | B1 |
6206841 | Cunningham et al. | Mar 2001 | B1 |
6214626 | Meller et al. | Apr 2001 | B1 |
6219574 | Cormier et al. | Apr 2001 | B1 |
6228100 | Schraga | May 2001 | B1 |
6230051 | Cormier et al. | May 2001 | B1 |
6231531 | Lum et al. | May 2001 | B1 |
6241862 | McAleer et al. | Jun 2001 | B1 |
6242207 | Douglas et al. | Jun 2001 | B1 |
6245215 | Douglas et al. | Jun 2001 | B1 |
6251083 | Yum et al. | Jun 2001 | B1 |
6251260 | Heller et al. | Jun 2001 | B1 |
6254586 | Mann et al. | Jul 2001 | B1 |
6255061 | Mori et al. | Jul 2001 | B1 |
6256533 | Yuzhakov et al. | Jul 2001 | B1 |
6268162 | Phillips et al. | Jul 2001 | B1 |
6271045 | Douglas et al. | Aug 2001 | B1 |
6272364 | Kurnik | Aug 2001 | B1 |
6283926 | Cunningham et al. | Sep 2001 | B1 |
6289230 | Chaiken et al. | Sep 2001 | B1 |
6298254 | Tamada | Oct 2001 | B2 |
6299578 | Kurnik et al. | Oct 2001 | B1 |
6299757 | Feldman et al. | Oct 2001 | B1 |
6306104 | Cunningham et al. | Oct 2001 | B1 |
6309351 | Kurnik et al. | Oct 2001 | B1 |
D450711 | Istvan et al. | Nov 2001 | S |
6312612 | Sherman et al. | Nov 2001 | B1 |
6312888 | Wong et al. | Nov 2001 | B1 |
6315738 | Nishikawa et al. | Nov 2001 | B1 |
6322808 | Trautman et al. | Nov 2001 | B1 |
6329161 | Heller et al. | Dec 2001 | B1 |
6331266 | Powell et al. | Dec 2001 | B1 |
6332871 | Douglas | Dec 2001 | B1 |
6334856 | Allen et al. | Jan 2002 | B1 |
6350273 | Minagawa et al. | Feb 2002 | B1 |
6352514 | Douglas et al. | Mar 2002 | B1 |
6356776 | Berner et al. | Mar 2002 | B1 |
6358265 | Thorne, Jr. et al. | Mar 2002 | B1 |
6364890 | Lum et al. | Apr 2002 | B1 |
6375626 | Allen et al. | Apr 2002 | B1 |
6375627 | Mauze et al. | Apr 2002 | B1 |
6379969 | Mauze et al. | Apr 2002 | B1 |
6391005 | Lum et al. | May 2002 | B1 |
6391645 | Huang et al. | May 2002 | B1 |
6402704 | McMorrow | Jun 2002 | B1 |
6409679 | Pyo | Jun 2002 | B2 |
6428664 | Bhullar et al. | Aug 2002 | B1 |
6449608 | Morita et al. | Sep 2002 | B1 |
6455324 | Douglas | Sep 2002 | B1 |
6493069 | Nagashimada et al. | Dec 2002 | B1 |
6500134 | Cassone | Dec 2002 | B1 |
6520973 | McGarry | Feb 2003 | B1 |
6530892 | Kelly | Mar 2003 | B1 |
6537243 | Henning et al. | Mar 2003 | B1 |
6540675 | Aceti et al. | Apr 2003 | B2 |
6544475 | Douglas et al. | Apr 2003 | B1 |
6549796 | Sohrab | Apr 2003 | B2 |
6555061 | Leong et al. | Apr 2003 | B1 |
6558624 | Lemmon et al. | May 2003 | B1 |
6571114 | Koike et al. | May 2003 | B1 |
6579690 | Bonnecaze et al. | Jun 2003 | B1 |
6589260 | Schmelzeisen-Redeker et al. | Jul 2003 | B1 |
6591125 | Buse et al. | Jul 2003 | B1 |
6602205 | Erickson et al. | Aug 2003 | B1 |
6612111 | Hodges et al. | Sep 2003 | B1 |
6616616 | Fritz et al. | Sep 2003 | B2 |
6626874 | Duchamp | Sep 2003 | B1 |
6656167 | Numao et al. | Dec 2003 | B2 |
6679852 | Schmelzeisen-Redeker et al. | Jan 2004 | B1 |
6706000 | Perez et al. | Mar 2004 | B2 |
6706049 | Moerman | Mar 2004 | B2 |
6706159 | Moerman et al. | Mar 2004 | B2 |
6740800 | Cunningham | May 2004 | B1 |
6743635 | Neel et al. | Jun 2004 | B2 |
6748275 | Lattner et al. | Jun 2004 | B2 |
6753187 | Cizdziel et al. | Jun 2004 | B2 |
6766817 | da Silva | Jul 2004 | B2 |
6793633 | Douglas et al. | Sep 2004 | B2 |
6830669 | Miyazaki et al. | Dec 2004 | B2 |
6836678 | Tu | Dec 2004 | B2 |
6837858 | Cunningham et al. | Jan 2005 | B2 |
6847451 | Pugh | Jan 2005 | B2 |
6849052 | Uchigaki et al. | Feb 2005 | B2 |
6896850 | Subramanian et al. | May 2005 | B2 |
6918404 | Da Silva | Jul 2005 | B2 |
6919960 | Hansen et al. | Jul 2005 | B2 |
6923764 | Aceti et al. | Aug 2005 | B2 |
6936476 | Anderson et al. | Aug 2005 | B1 |
D511214 | Sasano et al. | Nov 2005 | S |
6988996 | Roe et al. | Jan 2006 | B2 |
7004928 | Aceti et al. | Feb 2006 | B2 |
7011630 | Desai et al. | Mar 2006 | B2 |
7025774 | Freeman et al. | Apr 2006 | B2 |
D519868 | Sasano et al. | May 2006 | S |
7052652 | Zanzucchi et al. | May 2006 | B2 |
7066586 | Da Silva | Jun 2006 | B2 |
7066890 | Lam et al. | Jun 2006 | B1 |
7141058 | Briggs et al. | Nov 2006 | B2 |
7156809 | Quy | Jan 2007 | B2 |
7163616 | Vreeke et al. | Jan 2007 | B2 |
7192061 | Martin | Mar 2007 | B2 |
D540343 | Cummins | Apr 2007 | S |
7223365 | Freiherr Von Der Goltz | May 2007 | B2 |
7225008 | Ward et al. | May 2007 | B1 |
7226461 | Boecker et al. | Jun 2007 | B2 |
7258673 | Racchini et al. | Aug 2007 | B2 |
D551243 | Young | Sep 2007 | S |
7270970 | Anderson et al. | Sep 2007 | B2 |
7297151 | Boecker et al. | Nov 2007 | B2 |
7299081 | Mace et al. | Nov 2007 | B2 |
7343188 | Sohrab | Mar 2008 | B2 |
7344507 | Briggs et al. | Mar 2008 | B2 |
7379167 | Mawhirt et al. | May 2008 | B2 |
7427377 | Zanzucchi et al. | Sep 2008 | B2 |
D580068 | Shigesada et al. | Nov 2008 | S |
D580558 | Shigesada et al. | Nov 2008 | S |
D599373 | Kobayashi et al. | Sep 2009 | S |
D601257 | Berlinger | Sep 2009 | S |
7585278 | Aceti et al. | Sep 2009 | B2 |
D601444 | Jones et al. | Oct 2009 | S |
D601578 | Poulet et al. | Oct 2009 | S |
7682318 | Alden et al. | Mar 2010 | B2 |
D622393 | Gatrall et al. | Aug 2010 | S |
7780610 | Sonoda et al. | Aug 2010 | B2 |
7780631 | Lum et al. | Aug 2010 | B2 |
7803123 | Perez et al. | Sep 2010 | B2 |
7879058 | Ikeda | Feb 2011 | B2 |
7887494 | Emery et al. | Feb 2011 | B2 |
D642191 | Barnett et al. | Jul 2011 | S |
7988644 | Freeman et al. | Aug 2011 | B2 |
8012103 | Escutia et al. | Sep 2011 | B2 |
8012104 | Escutia et al. | Sep 2011 | B2 |
8105849 | McDevitt et al. | Jan 2012 | B2 |
D654926 | Lipman et al. | Feb 2012 | S |
8173439 | Petrich | May 2012 | B2 |
8184273 | Dosmann et al. | May 2012 | B2 |
8231832 | Zanzucchi et al. | Jul 2012 | B2 |
8251920 | Vreeke et al. | Aug 2012 | B2 |
8298255 | Conway et al. | Oct 2012 | B2 |
8303518 | Aceti et al. | Nov 2012 | B2 |
8360993 | Escutia et al. | Jan 2013 | B2 |
8360994 | Escutia et al. | Jan 2013 | B2 |
8372015 | Escutia et al. | Feb 2013 | B2 |
8376959 | Deck | Feb 2013 | B2 |
8382681 | Escutia et al. | Feb 2013 | B2 |
8391940 | Matzinger et al. | Mar 2013 | B2 |
D691174 | Lipman et al. | Oct 2013 | S |
8574168 | Freeman et al. | Nov 2013 | B2 |
8702624 | Alden | Apr 2014 | B2 |
8795201 | Escutia et al. | Aug 2014 | B2 |
8801631 | Escutia et al. | Aug 2014 | B2 |
8919605 | Lipman et al. | Dec 2014 | B2 |
8969097 | Emery et al. | Mar 2015 | B2 |
9060723 | Escutia et al. | Jun 2015 | B2 |
9060727 | Saikley et al. | Jun 2015 | B2 |
9095292 | Zanzucchi et al. | Aug 2015 | B2 |
9149215 | Werner et al. | Oct 2015 | B2 |
9226704 | Deck | Jan 2016 | B2 |
9366636 | Emery et al. | Jun 2016 | B2 |
20010001034 | Douglas | May 2001 | A1 |
20010027277 | Klitmose | Oct 2001 | A1 |
20010027328 | Lum et al. | Oct 2001 | A1 |
20010053891 | Ackley | Dec 2001 | A1 |
20020002326 | Causey, III et al. | Jan 2002 | A1 |
20020002344 | Douglas et al. | Jan 2002 | A1 |
20020004640 | Conn et al. | Jan 2002 | A1 |
20020006355 | Whitson | Jan 2002 | A1 |
20020016568 | Lebel et al. | Feb 2002 | A1 |
20020020688 | Sherman et al. | Feb 2002 | A1 |
20020022934 | Vogel et al. | Feb 2002 | A1 |
20020023852 | Mcivor et al. | Feb 2002 | A1 |
20020042594 | Lum et al. | Apr 2002 | A1 |
20020052618 | Haar et al. | May 2002 | A1 |
20020087056 | Aceti et al. | Jul 2002 | A1 |
20020136667 | Subramanian et al. | Sep 2002 | A1 |
20020137998 | Smart et al. | Sep 2002 | A1 |
20020160520 | Orloff et al. | Oct 2002 | A1 |
20020168290 | Yuzhakov et al. | Nov 2002 | A1 |
20020169394 | Eppstein | Nov 2002 | A1 |
20020169411 | Sherman et al. | Nov 2002 | A1 |
20020177761 | Orloff et al. | Nov 2002 | A1 |
20020177764 | Sohrab | Nov 2002 | A1 |
20020183102 | Withers et al. | Dec 2002 | A1 |
20020188223 | Perez et al. | Dec 2002 | A1 |
20020188224 | Roe et al. | Dec 2002 | A1 |
20020198444 | Uchigaki et al. | Dec 2002 | A1 |
20030012693 | Otillar et al. | Jan 2003 | A1 |
20030028087 | Yuzhakov et al. | Feb 2003 | A1 |
20030028125 | Yuzhakov et al. | Feb 2003 | A1 |
20030039587 | Niermann | Feb 2003 | A1 |
20030060730 | Perez | Mar 2003 | A1 |
20030083685 | Freeman et al. | May 2003 | A1 |
20030083686 | Freeman et al. | May 2003 | A1 |
20030105961 | Zatloukal et al. | Jun 2003 | A1 |
20030116596 | Terasawa | Jun 2003 | A1 |
20030135166 | Gonnelli | Jul 2003 | A1 |
20030135333 | Aceti | Jul 2003 | A1 |
20030143746 | Sage | Jul 2003 | A1 |
20030153844 | Smith et al. | Aug 2003 | A1 |
20030153900 | Aceti et al. | Aug 2003 | A1 |
20030175987 | Verdonk et al. | Sep 2003 | A1 |
20030206302 | Pugh | Nov 2003 | A1 |
20030207441 | Eyster et al. | Nov 2003 | A1 |
20030208113 | Mault et al. | Nov 2003 | A1 |
20030211619 | Olson et al. | Nov 2003 | A1 |
20030212344 | Yuzhakov et al. | Nov 2003 | A1 |
20030212345 | McAllister et al. | Nov 2003 | A1 |
20030212347 | Sohrab | Nov 2003 | A1 |
20030216628 | Bortz et al. | Nov 2003 | A1 |
20040010207 | Flaherty et al. | Jan 2004 | A1 |
20040030353 | Schmelzeisen-Redeker et al. | Feb 2004 | A1 |
20040049219 | Briggs et al. | Mar 2004 | A1 |
20040059256 | Perez | Mar 2004 | A1 |
20040072357 | Stiene et al. | Apr 2004 | A1 |
20040073140 | Douglas et al. | Apr 2004 | A1 |
20040092842 | Boecker et al. | May 2004 | A1 |
20040092995 | Boecker et al. | May 2004 | A1 |
20040094432 | Neel et al. | May 2004 | A1 |
20040096959 | Stiene et al. | May 2004 | A1 |
20040097796 | Berman et al. | May 2004 | A1 |
20040098009 | Boecker et al. | May 2004 | A1 |
20040102803 | Boecker et al. | May 2004 | A1 |
20040122339 | Roe et al. | Jun 2004 | A1 |
20040132167 | Rule et al. | Jul 2004 | A1 |
20040138588 | Saikley et al. | Jul 2004 | A1 |
20040155084 | Brown | Aug 2004 | A1 |
20040157339 | Burke et al. | Aug 2004 | A1 |
20040178218 | Schomakers et al. | Sep 2004 | A1 |
20040186394 | Roe et al. | Sep 2004 | A1 |
20040191119 | Zanzucchi et al. | Sep 2004 | A1 |
20040202576 | Aceti et al. | Oct 2004 | A1 |
20040230216 | Levaughn et al. | Nov 2004 | A1 |
20040232180 | Badillo | Nov 2004 | A1 |
20040236251 | Roe et al. | Nov 2004 | A1 |
20040238675 | Banaszkiewicz et al. | Dec 2004 | A1 |
20040242982 | Sakata et al. | Dec 2004 | A1 |
20040249253 | Racchini et al. | Dec 2004 | A1 |
20040259180 | Burke et al. | Dec 2004 | A1 |
20050004494 | Perez et al. | Jan 2005 | A1 |
20050010134 | Douglas et al. | Jan 2005 | A1 |
20050015020 | LeVaughn et al. | Jan 2005 | A1 |
20050027182 | Siddiqui et al. | Feb 2005 | A1 |
20050070819 | Poux et al. | Mar 2005 | A1 |
20050096686 | Allen | May 2005 | A1 |
20050106713 | Phan et al. | May 2005 | A1 |
20050109386 | Marshall | May 2005 | A1 |
20050159678 | Taniike et al. | Jul 2005 | A1 |
20050187532 | Thurau et al. | Aug 2005 | A1 |
20050202567 | Zanzucchi et al. | Sep 2005 | A1 |
20050202733 | Yoshimura et al. | Sep 2005 | A1 |
20050209518 | Sage, Jr. et al. | Sep 2005 | A1 |
20050215872 | Berner et al. | Sep 2005 | A1 |
20050215923 | Wiegel | Sep 2005 | A1 |
20050234486 | Allen et al. | Oct 2005 | A1 |
20050245844 | Mace et al. | Nov 2005 | A1 |
20050277972 | Wong et al. | Dec 2005 | A1 |
20060008389 | Sacherer et al. | Jan 2006 | A1 |
20060036134 | Tarassenko et al. | Feb 2006 | A1 |
20060052724 | Roe | Mar 2006 | A1 |
20060064035 | Wang et al. | Mar 2006 | A1 |
20060094985 | Aceti et al. | May 2006 | A1 |
20060117616 | Jones et al. | Jun 2006 | A1 |
20060122536 | Haar et al. | Jun 2006 | A1 |
20060135873 | Karo et al. | Jun 2006 | A1 |
20060155317 | List | Jul 2006 | A1 |
20060161078 | Schraga | Jul 2006 | A1 |
20060178600 | Kennedy et al. | Aug 2006 | A1 |
20060184189 | Olson et al. | Aug 2006 | A1 |
20060189908 | Kennedy | Aug 2006 | A1 |
20060204399 | Freeman et al. | Sep 2006 | A1 |
20060229533 | Hoenes et al. | Oct 2006 | A1 |
20060241517 | Fowler et al. | Oct 2006 | A1 |
20060257993 | Mcdevitt et al. | Nov 2006 | A1 |
20060259102 | Slatkine | Nov 2006 | A1 |
20060281187 | Emery et al. | Dec 2006 | A1 |
20070016104 | Jansen et al. | Jan 2007 | A1 |
20070017824 | Rippeth et al. | Jan 2007 | A1 |
20070060842 | Alvarez-Icaza et al. | Mar 2007 | A1 |
20070078313 | Emery et al. | Apr 2007 | A1 |
20070078358 | Escutia et al. | Apr 2007 | A1 |
20070083130 | Thomson et al. | Apr 2007 | A1 |
20070083131 | Escutia et al. | Apr 2007 | A1 |
20070112281 | Olson | May 2007 | A1 |
20070179404 | Escutia et al. | Aug 2007 | A1 |
20070179405 | Emery et al. | Aug 2007 | A1 |
20070253531 | Okuzawa et al. | Nov 2007 | A1 |
20070255181 | Alvarez-Icaza et al. | Nov 2007 | A1 |
20070255302 | Koeppel et al. | Nov 2007 | A1 |
20080046831 | Imai et al. | Feb 2008 | A1 |
20080077048 | Escutia et al. | Mar 2008 | A1 |
20080139910 | Mastrototaro et al. | Jun 2008 | A1 |
20080194934 | Ray et al. | Aug 2008 | A1 |
20080269625 | Halperin et al. | Oct 2008 | A1 |
20090054810 | Zanzucchi et al. | Feb 2009 | A1 |
20090099437 | Yuzhakov | Apr 2009 | A1 |
20090156923 | Power et al. | Jun 2009 | A1 |
20090292489 | Burke et al. | Nov 2009 | A1 |
20090301899 | Hodges et al. | Dec 2009 | A1 |
20100010374 | Escutia et al. | Jan 2010 | A1 |
20100021947 | Emery et al. | Jan 2010 | A1 |
20100021948 | Lipman et al. | Jan 2010 | A1 |
20100095229 | Dixon et al. | Apr 2010 | A1 |
20100174211 | Frey et al. | Jul 2010 | A1 |
20100185120 | Sacherer et al. | Jul 2010 | A1 |
20100217155 | Poux et al. | Aug 2010 | A1 |
20100331650 | Batman et al. | Dec 2010 | A1 |
20110098599 | Emery et al. | Apr 2011 | A1 |
20110105872 | Chickering, III et al. | May 2011 | A1 |
20110201909 | Emery et al. | Aug 2011 | A1 |
20110294152 | Lipman et al. | Dec 2011 | A1 |
20120166090 | Lipman et al. | Jun 2012 | A1 |
20120296179 | Zanzucchi et al. | Nov 2012 | A1 |
20130110516 | Abulhaj et al. | May 2013 | A1 |
20130158430 | Aceti et al. | Jun 2013 | A1 |
20130158432 | Escutia et al. | Jun 2013 | A1 |
20130172698 | Reynolds et al. | Jul 2013 | A1 |
20130274568 | Escutia et al. | Oct 2013 | A1 |
20130274579 | Richter et al. | Oct 2013 | A1 |
20140316301 | Escutia et al. | Oct 2014 | A1 |
20140336480 | Escutia et al. | Nov 2014 | A1 |
20140376762 | Lipman et al. | Dec 2014 | A1 |
20150037898 | Baldus et al. | Feb 2015 | A1 |
20150153351 | Lipman et al. | Jun 2015 | A1 |
20150212006 | Emery et al. | Jul 2015 | A1 |
20160038066 | Escutia et al. | Feb 2016 | A1 |
Number | Date | Country |
---|---|---|
2 201 530 | Sep 1997 | CA |
2 513 465 | Aug 2004 | CA |
197 05 091 | Feb 1999 | DE |
199 22 413 | Nov 2000 | DE |
103 02-501 | Aug 2004 | DE |
0 103 426 | Mar 1984 | EP |
0 256 806 | Feb 1988 | EP |
0 396-016 | Nov 1990 | EP |
0 396-016 | Nov 1990 | EP |
0 397 424 | Nov 1990 | EP |
0 255-338 | Feb 1998 | EP |
0 849 584 | Jun 1998 | EP |
1 266-607 | Dec 2002 | EP |
1 266-607 | Dec 2002 | EP |
1 369 688 | Oct 2003 | EP |
1 369 688 | Oct 2003 | EP |
1 360-934 | Nov 2003 | EP |
1 360-934 | Nov 2003 | EP |
1 486-766 | Dec 2004 | EP |
1 486-766 | Dec 2004 | EP |
1 529-489 | May 2005 | EP |
1 529-489 | May 2005 | EP |
1 586270 | Oct 2005 | EP |
1 586270 | Oct 2005 | EP |
1 769-735 | Apr 2007 | EP |
63-305841 | Dec 1988 | JP |
3-63570 | Mar 1991 | JP |
03093189 | Apr 1991 | JP |
7-67861 | Mar 1995 | JP |
7-213925 | Aug 1995 | JP |
09-084781 | Mar 1997 | JP |
9-168530 | Jun 1997 | JP |
9-313465 | Sep 1997 | JP |
9-266889 | Oct 1997 | JP |
9-294737 | Nov 1997 | JP |
10024028 | Jan 1998 | JP |
10-505258 | May 1998 | JP |
10-508518 | Aug 1998 | JP |
10-318970 | Dec 1998 | JP |
63-305841 | Dec 1998 | JP |
11-056822 | Mar 1999 | JP |
11-281779 | Oct 1999 | JP |
2000-126161 | May 2000 | JP |
2000-168754 | Jun 2000 | JP |
2000-254111 | Sep 2000 | JP |
2001-017404 | Jan 2001 | JP |
2001-159618 | Jun 2001 | JP |
2001-515203 | Sep 2001 | JP |
2001-305096 | Oct 2001 | JP |
2001-309905 | Nov 2001 | JP |
2001-330581 | Nov 2001 | JP |
2002-000588 | Jan 2002 | JP |
2002-502045 | Jan 2002 | JP |
2002-085384 | Mar 2002 | JP |
2002-514453 | May 2002 | JP |
2002-219155 | Aug 2002 | JP |
2003-507719 | Feb 2003 | JP |
2003-108679 | Apr 2003 | JP |
2003-180417 | Jul 2003 | JP |
2004-000598 | Jan 2004 | JP |
2004-500948 | Jan 2004 | JP |
2004-117339 | Apr 2004 | JP |
2004-202256 | Jul 2004 | JP |
2004-208727 | Jul 2004 | JP |
2004-209266 | Jul 2004 | JP |
2004-519302 | Jul 2004 | JP |
2004-522500 | Jul 2004 | JP |
2004-528936 | Sep 2004 | JP |
2005-009238 | Jan 2005 | JP |
3638958 | Jan 2005 | JP |
2005-503538 | Feb 2005 | JP |
2005-087613 | Apr 2005 | JP |
2006-512969 | Apr 2005 | JP |
2005-523065 | Aug 2005 | JP |
2005-525149 | Aug 2005 | JP |
2005-237938 | Sep 2005 | JP |
2005-525846 | Sep 2005 | JP |
2005-527254 | Sep 2005 | JP |
2005-305157 | Nov 2005 | JP |
2005-305159 | Nov 2005 | JP |
2006-506185 | Feb 2006 | JP |
2006-512974 | Apr 2006 | JP |
2006-516723 | Jul 2006 | JP |
2006-521555 | Sep 2006 | JP |
2006-527013 | Nov 2006 | JP |
2007-014381 | Jan 2007 | JP |
2007-054407 | Mar 2007 | JP |
2007-136198 | Jun 2007 | JP |
2007-521031 | Aug 2007 | JP |
2007-537804 | Dec 2007 | JP |
2008-125813 | Jun 2008 | JP |
WO-8605966 | Oct 1986 | WO |
WO-8800812 | Feb 1988 | WO |
WO-8807666 | Oct 1988 | WO |
WO-9114212 | Sep 1991 | WO |
WO-9413203 | Jun 1994 | WO |
WO-9510223 | Apr 1995 | WO |
WO-9510223 | Apr 1995 | WO |
WO-9604857 | Feb 1996 | WO |
WO-9607907 | Mar 1996 | WO |
WO-9614026 | May 1996 | WO |
WO-9625088 | Aug 1996 | WO |
WO-9704707 | Feb 1997 | WO |
WO-9715227 | May 1997 | WO |
WO-9729847 | Aug 1997 | WO |
WO-9730344 | Aug 1997 | WO |
WO-9741421 | Nov 1997 | WO |
WO-9742885 | Nov 1997 | WO |
WO-9742888 | Nov 1997 | WO |
WO-9743962 | Nov 1997 | WO |
WO-9800193 | Jan 1998 | WO |
WO-9831275 | Jul 1998 | WO |
WO-9835225 | Aug 1998 | WO |
WO-9912008 | Mar 1999 | WO |
WO-9923492 | May 1999 | WO |
WO-9944508 | Sep 1999 | WO |
WO-9956954 | Nov 1999 | WO |
WO-9958051 | Nov 1999 | WO |
WO-9962576 | Dec 1999 | WO |
WO-0009184 | Feb 2000 | WO |
WO-0013573 | Mar 2000 | WO |
WO-0014269 | Mar 2000 | WO |
WO-0014535 | Mar 2000 | WO |
WO-0018449 | Apr 2000 | WO |
WO-0018449 | Jun 2000 | WO |
WO-0036400 | Jun 2000 | WO |
WO-0042422 | Jul 2000 | WO |
WO-0074763 | Dec 2000 | WO |
WO-0074763 | Dec 2000 | WO |
WO-0078208 | Dec 2000 | WO |
WO-0113795 | Mar 2001 | WO |
WO-0116575 | Mar 2001 | WO |
WO-0152727 | Jul 2001 | WO |
WO-0164105 | Sep 2001 | WO |
WO-0164105 | Sep 2001 | WO |
WO-0172220 | Oct 2001 | WO |
WO-0180728 | Nov 2001 | WO |
WO-0185233 | Nov 2001 | WO |
WO-0185233 | Nov 2001 | WO |
WO-0191634 | Dec 2001 | WO |
WO-0191634 | Dec 2001 | WO |
WO-0200101 | Jan 2002 | WO |
WO-0200101 | Jan 2002 | WO |
WO 0249507 | Jun 2002 | WO |
WO-0249509 | Jun 2002 | WO |
WO-0249509 | Jun 2002 | WO |
WO-02078533 | Oct 2002 | WO |
WO-02078533 | Oct 2002 | WO |
WO-02082052 | Oct 2002 | WO |
WO-02082052 | Oct 2002 | WO |
WO-02093144 | Nov 2002 | WO |
WO-02100251 | Dec 2002 | WO |
WO-02100251 | Dec 2002 | WO |
WO-02101359 | Dec 2002 | WO |
WO-02101359 | Dec 2002 | WO |
WO-03007819 | Jan 2003 | WO |
WO-03030984 | Apr 2003 | WO |
WO-03066128 | Aug 2003 | WO |
WO-03066128 | Aug 2003 | WO |
WO-03070099 | Aug 2003 | WO |
WO-03071940 | Sep 2003 | WO |
WO-03071940 | Sep 2003 | WO |
WO-03088834 | Oct 2003 | WO |
WO-2004045375 | Jun 2004 | WO |
WO-2004045375 | Jun 2004 | WO |
WO-2004062499 | Jul 2004 | WO |
WO-2004062500 | Jul 2004 | WO |
WO-2004062500 | Jul 2004 | WO |
WO-2004064636 | Aug 2004 | WO |
WO-2004085995 | Oct 2004 | WO |
WO-2004085995 | Oct 2004 | WO |
WO-2004091693 | Oct 2004 | WO |
WO-2004091693 | Oct 2004 | WO |
WO-2004105827 | Dec 2004 | WO |
WO-2004105827 | Dec 2004 | WO |
WO 2005006939 | Jan 2005 | WO |
WO-2005009238 | Feb 2005 | WO |
WO-2005013824 | Feb 2005 | WO |
WO-2005018709 | Mar 2005 | WO |
WO-2005018709 | Mar 2005 | WO |
WO-2005018710 | Mar 2005 | WO |
WO-2005018710 | Mar 2005 | WO |
WO-2005084543 | Sep 2005 | WO |
WO-2005084546 | Sep 2005 | WO |
WO-2005084546 | Sep 2005 | WO |
WO-2005085995 | Sep 2005 | WO |
WO-2005112763 | Dec 2005 | WO |
WO-2006138226 | Dec 2006 | WO |
WO-2006138226 | Dec 2006 | WO |
WO-2007041062 | Apr 2007 | WO |
WO-2007041062 | Apr 2007 | WO |
WO-2007041063 | Apr 2007 | WO |
WO-2007041063 | Apr 2007 | WO |
WO-2007041244 | Apr 2007 | WO |
WO-2007041244 | Apr 2007 | WO |
WO-2007041287 | Apr 2007 | WO |
WO-2007041287 | Apr 2007 | WO |
WO-2007041355 | Apr 2007 | WO |
WO-2007041355 | Apr 2007 | WO |
WO-2007108519 | Sep 2007 | WO |
WO-2007112034 | Oct 2007 | WO |
WO-2007112034 | Oct 2007 | WO |
WO-2008027319 | Mar 2008 | WO |
WO-2008027319 | Mar 2008 | WO |
WO-2008062648 | May 2008 | WO |
WO 2009145920 | Dec 2009 | WO |
WO-2009148624 | Dec 2009 | WO |
WO-2009148626 | Dec 2009 | WO |
WO-2011065981 | Jun 2011 | WO |
WO-2011162823 | Dec 2011 | WO |
WO-2013020103 | Feb 2013 | WO |
WO-2014205412 | Dec 2014 | WO |
Entry |
---|
Machine Translation of Claims and Detailed Description of JP 09-266889A, produced Dec. 14, 2007. Japanese Patent Office Website pp. 1-9. |
Machine Translation of Description of Drawings of JP 09-266889A, produced Dec. 14, 2007. Japanese Patent Office Website pp. 1-2. |
ADA Consensus Development Panel. (Jan.-Feb. 1987). “Consensus Statement on Self-Monitoring of Blood Glucose,” Diabetes Care 10(1):95-99. |
ADA (Jan. 1994). “Self-Monitoring of Blood Glucose,” Consensus Statement Diabetes Care 17(1):81-86. |
Anonymous. (Sep. 30, 1993). “The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus.” The New England Journal of Medicine 329(14):977-986. |
Anonymous. (Jun. 23, 1998). Taking the “Ouch” Out of Needles: Arrays of “Microneedles” Offer New Techniques for Drug Delivery, Science Daily, located at <http:www.sciencedaily.com/releases/1998/06/980623045850.htm>, last visited Jan. 14, 2014, 3 pages. |
Beregszàszi, M. et al. (Jul. 1997). “Nocturnal Hypoglycemia in Children and Adolescents with Insulin-Dependent Diabetes Mellitus: Prevalence and Risk Factors,” J. Pediatrics 131(1 Pt. 1):27-33. |
Chase, H.P. et al. (Feb. 2001). “Continuous Subcutaneous Glucose Monitoring in Children with Type 1 Diabetes,” Pediatrics 107(2):222-226. |
Clarke, W.L. et al. (Sep.-Oct. 1987). “Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose,” Diabetes Care 10(5):622-628. |
Collison, M.E. et al. (Sep. 1999). “Analytical Characterization of Electrochemical Biosensor Test Strips for Measurement of Glucose in Low-Volume Interstitial Fluid Samples,” Clinical Chemistry 45(9):1665-1673. |
Coster, S. et al. (2000). “Monitoring Blood Glucose Control in Diabetes Mellitus: A Systematic Review.” Health Technology Assessment 4(12):1-93. |
Cox, D.J. et al. (Jun. 1997). “Understanding Error Grid Analysis,” Diabetes Care 20(6):911-912. |
D'Arrigo, T.D. (Mar. 2000). “GlucoWatch Monitor Poised for Approval,” Diabetes Forecast, 53(3):43-44. |
Feldman, B. et al. (2000). “FreeStyle™: A Small-Volume Electrochemical Glucose Sensor for Home Blood Glucose Testing,” Diabetes Technology and Therapeutics, 2(2):221-229. |
International Search Report dated Jul. 16, 2009, for PCT Application No. PCT/US2009/003318 filed on Jun. 1, 2009, 3 pages. |
Johnson, R.N. et al. (Jan. 1998). “Accuracy of Devices Used for Self-Monitoring of Blood Glucose,” Annals of Clinical Biochemistry 35(1):68-74. |
Johnson, R.N. et al. (Jan. 1999). “Analytical Error of Home Glucose Monitors: A Comparison of 18 Systems,” Annals of Clinical Biochemistry 36(1):72-79. |
Johnson, R.N. et al. (2001). “Error Detection and Measurement in Glucose Monitors,” Clinica Chimica Acta 307:61-67. |
Kumetrix, Inc. (Dec. 1999). “Painless Blood Glucose Monitoring, Courtesy of the Mosquito,” Start-Up pp. 27-28. |
Lee, S-C. (Jun. 1999). “Light Scattering by Closely Spaced Parallel Cylinders Embedded in a Finite Dielectric Slab,” Journal of the Optical Society of America A 16(6):1350-1361. |
McGarraugh, G. et al. (2001). “Physiological Influences on Off-Finger Glucose Testing,” Diabetes Technology & Therapeutics 3(3):367-376. |
McNichols, R.J. et al. (Jan. 2000). “Optical Glucose Sensing in Biological Fluids: An Overview,” Journal of Biomedical Optics, 5(1):5-16. |
Mahler, R.J. et al. (1999). “Clinical Review 102, Type 2 Diabetes Melitus: Update on Diagnosis Pathophysiology, and Treatment,” The Journal of Clinical Endocrinology and Metabolism 84(4):1165-1171. |
Medline Plus. (Jun. 17, 2008). Medical Encyclopedia, Monitor Blood Glucose—Series: Part 1-4, 6 pages. |
Neeley, W.E. et al. (1981). “An Instrument for Digital Matrix Photometry,” Clinical Chemistry 27(10):1665-1668. |
Neeley, W.E. (1983). “Reflectance Digital Matrix Photometry,” Clinical Chemistry 29(6):1038-1041. |
Neeley, W.E. (1983). “Multilayer Film Analysis for Glucose in 1-μL Samples of Plasma,” Clinical Chemistry 29(12):2103-2105. |
Neeley, W.E. (1988). “A Reflectance Photometer with a Square Photodiode Array Detector for Use on Multilayer Dry-Film Slides,” Clinical Chemistry 34(11):2367-2370. |
Otto, E. et al. (2000). “An Intelligent Diabetes Software Prototype: Predicting Blood Glucose Levels and Recommending Regimen Changes,” Diabetes Technology and Therapeutics 2(4):569-576. |
Pfohl, M. et al. (2000). “Spot Glucose Measurement in Epidermal Interstitial Fluid—An Alternative to Capillary Blood Glucose Estimation,” Experimental and Clinical Endocrinology & Diabetes 108(1):1-4. |
Princen, H.M. (May 1969). “Capillary Phenomena in Assemblies of Parallel Cylinders, I. Capillary Rise Between Two Cylinders,” Journal of Colloid and Interface Science 30(1):69-75. |
Princen, H.M. (Jul. 1969). “Capillary Phenomena in Assemblies of Parallel Cylinders, II. Capillary Rise in Systems with More Than Two Cylinders,” Journal of Colloid and Interface Science 30(3):359-371. |
Rebrin, K. et al. (Sep. 1999). “Subcutaneous Glucose Predicts Plasma Glucose Independent of Insulin: Implications for Continuous Monitoring,” American Journal of Physiology 277(3):E561-E571. |
Rosen, S. (1999). “Road to New-Age Glucose Monitoring Still Rocky,” Diagnostic Insight, pp. 4-5, 12-13, 16. |
Smart, W.H. et al. (2000). “The Use of Silicon Microfabrication Technology in Painless Glucose Monitoring,” Diabetes Technology & Therapeutics 2(4):549-559. |
Svedman, C. et al. (Apr. 1999). “Skin Mini-Erosion Technique for Monitoring Metabolites in Interstitial Fluid: Its Feasibility Demonstrated by OGTT Results in Diabetic and Non-Diabetic Subjects,” Scand. J. Clin. Lab. Invest. 59(2):115-123. |
Trinder, P. (1969). “Determination of Glucose in Blood Using Glucose Oxidase with an Alternate Oxygen Acceptor,” Annals of Clinical Biochemistry 6:24-28. |
Written Opinion dated Jul. 16, 2009, for PCT Application No. PCT/US2009/003318 filed on Jun. 1, 2009, 8 pages. |
Yum, S. I. et al. (Nov. 1, 1999). “Capillary Blood Sampling for Self-Monitoring of Blood Glucose,” Diabetes Technology & Therapeutics, 1(1):29-37. |
Brazzle, J. et al. Active Microneedles with Integrated Functionality, Solid-State Sensor and Actuator Workshop, Hilton Head Island, South Carolina, Jun. 4-8, 2000, Technical Digest, 199-202. |
Burge, M.R., (Aug. 2001). “Lack of Compliance with Home Blood Glucose Monitoring Predicts Hospitalization in Diabetes”, Diabetes Care 24(8): 1502-1503. |
Clarke, W.L. et al. (Sep.-Oct. 1981). “Evaluation of a New Reflectance Photometer for Use in Home Blood Glucose Monitoring,” Diabetes Care, 4(5):547-550. |
Extended European Search Report dated Feb. 2, 2016 for European Patent Application No. 15187274.4, filed on Sep. 29, 2015, 6 pages. |
Extended European Search Report dated Apr. 19, 2011, for EP Application No. 10 18 0848.3 filed Sep. 28, 2010, 5 pages. |
Extended European Search Report dated Feb. 22, 2012, for EP Application No. EP 10 18 1155.2, filed Sep. 28, 2010, six pages. |
Extended European Search Report dated Jan. 22, 2013, for EP Application No. 12182900.6, filed on Sep. 29, 2006, 6 pages. |
Extended European Search Report dated Apr. 29, 2013 for EP Patent Application No. 12192620.8, filed on Nov. 14, 2012, 8 pages. |
Extended European Search Report dated Nov. 8, 2016, for EP Application No. 16 167 087.2, filed on Aug. 3, 2012, 6 pages. |
Extended European Search Report dated Jun. 8, 2011, for EP Application No. 07 837 337.0, filed on Aug. 27, 2007, 5 pages. |
Final Office Action dated Jul. 9, 2008, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 19 pages. |
Final Office Action dated Nov. 23, 2009, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 20 pages. |
Final Office Action dated Jan. 21, 2011, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 7 pages. |
Final Office Action dated Apr. 13, 2016, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 31 pages. |
Final Office Action dated Aug. 15, 2013, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 12 pages. |
Final Office Action dated Aug. 28, 2014, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 11 pages. |
Final Office Action dated Dec. 26, 2014, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 9 pages. |
Final Office Action dated Jan. 22, 2014, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 8 pages. |
Final Office Action dated Jun. 30, 2010, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 11 pages. |
Final Office Action dated May 30, 2007, for U.S. Appl. No. 11/125,107, filed May 10, 2005, 11 pages. |
Final Office Action dated Nov. 1, 2010, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 9 pages. |
Final Office Action dated Nov. 21, 2011, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 8 pages. |
Final Office Action dated Jun. 11, 2010, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 16 pages. |
Final Office Action dated Mar. 10, 2015, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 24 pages. |
Final Office Action mailed on Dec. 16, 2008, for U.S. Appl. No. 11/510,784, filed Aug. 28, 2006, 15 pages. |
Final Office Action dated Jul. 26, 2010, for U.S. Appl. No. 11/510,784, filed Aug. 28, 2006, 30 pages. |
Hemmerich, K.J. et al. (Apr. 1995). “Guide to Engineering Thermoplastics,” Medical Devices and Diagnostic Industry pp. 39-59. |
Integ. (2000). “LifeGuide™ Glucose Meter. No Lancets. No Blood,” located at <http://www.integonline.com>, last visited May 1, 2000, 10 pages. |
International Search Report dated May 2, 2007, for PCT Application No. PCT/US2006/37923, filed on Sep. 9, 2006, 1 page. |
International Search Report dated Dec. 3, 2004, for PCT Application No. PCT/US2004/08798, filed on Mar. 24, 2004, 3 pages. |
International Search Report dated Aug. 16, 2007 for PCT Application No. PCT/US2006/038163, filed on Sep. 29, 2006, 1 page. |
International Search Report dated Aug. 17, 2007 for PCT/US2006/38049, filed on Sep. 29, 2006, 1 page. |
International Search Report dated Oct. 19, 2012 for PCT Application No. PCT/US2012/049629, filed on Aug. 3, 2012, 3 pages. |
International Search Report dated Mar. 3, 2008, for PCT Application No. PCT/US2007/018780, filed on Aug. 27, 2007, 2 pages. |
Ishii H. et al., (Aug. 2001). “Seasonal Variation of Glycemic Control in Type 2 Diabetic Patients”, Diabetes Care 24(8):1503. |
Massey V. et al. (Aug. 1960). “Studies on the Reaction Mechanism of Lipoyl Dehydrogenase” Biochim. Biophys. Acta 48: 33-47. |
Non-Final Office Action dated Dec. 12, 2007, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 13 pages. |
Non-Final Office Action dated Apr. 28, 2009, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 21 pages. |
Non-Final Office Action dated Jun. 4, 2010, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 23 pages. |
Non-Final Office Action dated Mar. 23, 2012, for U.S. Appl. No. 13/197,592, filed Aug. 3, 2011, 7 pages. |
Non-Final Office Action dated Mar. 23, 2012, for U.S. Appl. No. 13/197,603, filed Aug. 3, 2011, 6 pages. |
Non-Final Office Action dated Nov. 26, 2012 for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 9 pages. |
Non Final Office Action dated Apr. 8, 2015, for U.S. Appl. No. 13/566,886, filed Aug. 3, 2012, 11 pages. |
Non Final Office Action dated Apr. 12, 2011, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 7 pages. |
Non Final Office Action dated Aug. 5, 2014, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 8 pages. |
Non Final Office Action dated Dec. 5, 2014, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 7 pages. |
Non Final Office Action dated Jan. 12, 2009, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 9 pages. |
Non Final Office Action dated Jan. 21, 2011, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 9 pages. |
Non Final Office Action dated Jul. 13, 2010, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 11 pages. |
Non Final Office Action dated Jul. 31, 2015, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 16 pages. |
Non Final Office Action dated Mar. 21, 2014, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 12 pages. |
Non Final Office Action dated Mar. 25, 2011, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 13 pages. |
Non Final Office Action dated Mar. 5, 2010, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 8 pages. |
Non Final Office Action dated May 14, 2008, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 9 pages. |
Non Final Office Action dated May 16, 2013, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 8 pages. |
Non Final Office Action dated May 5, 2005, for U.S. Appl. No. 10/131,268, filed Apr. 23, 2002, 8 pages. |
Non Final Office Action dated Nov. 2, 2006, for U.S. Appl. No. 11/125,107, filed May 10, 2005, 10 pages. |
Non Final Office Action dated Nov. 26, 2012, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 9 pages. |
Non Final Office Action dated Oct. 14, 2009, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 10 pages. |
Non Final Office Action dated Oct. 3, 2008, for U.S. Appl. No. 10/722,074, filed Nov. 24, 2003, 10 pages. |
Non- Final Office Action dated Dec. 17, 2015, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 6 pages. |
Non Final Office Action dated Dec. 2, 2004, for U.S. Appl. No. 10/347,620, filed Jan. 22, 2003, 8 pages. |
Non-Final Office Action dated Jan. 27, 2009, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 17 pages. |
Non-Final Office Action dated Jan. 6, 2014, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 12 pages. |
Non-Final Office Action dated Jun. 21, 2013, for U.S. Appl. No. 13/752,261, filed Jan. 28, 2013, 12 pages. |
Non-Final Office Action dated Jun. 6, 2008, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 17 pages. |
Non-Final Office Action dated Oct. 9, 2014, for U.S. Appl. No. 14/446,262, filed Jul. 29, 2014, 15 pages. |
Non Final Office Action dated Sep. 29, 2004, for U.S. Appl. No. 10/394,230, filed Mar. 24, 2003, 10 pages. |
Non-Final Office Action dated Dec. 19, 2007, for U.S. Appl. No. 11/510,784, filed Aug. 28, 2006, 17 pages. |
Non-Final Office Action dated May 11, 2009, for U.S. Appl. No. 11/510,784, filed Aug. 28, 2006, 13 pages. |
Non-Final Office Action dated Jan. 13, 2010, for U.S. Appl. No. 11/510,784, filed Aug. 28, 2006, 18 pages. |
Non-Final Office Action dated Aug. 11, 2011, for U.S Appl. No. 11/510,784, filed Aug. 28, 2006, 35 pages. |
Notice of Allowance dated Oct. 3, 2012, for U.S. Appl. No. 11/510,784, filed Aug. 28, 2006, 10 pages. |
Notice of Allowance dated Apr. 18, 2012, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 8 pages. |
Notice of Allowance dated Apr. 19, 2010, for U.S. Appl. No. 29/338,117, filed Jun. 4, 2009, 4 pages. |
Notice of Allowance dated Aug. 3, 2012, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 5 pages. |
Notice of Allowance dated Jan. 14, 2010, for U.S. Appl. No. 29/338,117, filed Jun. 4, 2009, 4 pages. |
Notice of Allowance dated Jun. 29, 2012, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 5 pages. |
Notice of Allowance dated Mar. 14, 2012, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 7 pages. |
Notice of Allowance dated Mar. 27, 2015, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 7 pages. |
Notice of Allowance dated Mar. 31, 2005, for U.S. Appl. No. 10/394,230, filed Mar. 24, 2003, 10 pages. |
Notice of Allowance dated May 15, 2008, for U.S. Appl. No. 11/125,107, filed May 10, 2005, 7 pages. |
Notice of Allowance dated May 18, 2009, for U.S. Appl. No. 29/300,934, filed May 30, 2008, 4 pages. |
Notice of Allowance dated May 28, 2009, for U.S. Appl. No. 29/300,933, filed May 30, 2008, 6 pages. |
Notice of Allowance dated Nov. 23, 2011, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 7 pages. |
Notice of Allowance dated Nov. 27, 2012, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 5 pages. |
Notice of Allowance dated Nov. 29, 2005, for U.S. Appl. No. 10/131,268, filed Apr. 23, 2002, 6 pages. |
Notice of Allowance dated Oct. 12, 2011, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 8 pages. |
Notice of Allowance dated Feb. 23, 2015, for U.S. Appl. No. 14/446,262, filed Jul. 29, 2014, 8 pages. |
Notice of Allowance dated Feb. 5, 2014, for U.S. Appl. No. 13/752,261, filed Jan. 28, 2013, 9 pages. |
Notice of Allowance dated Jun. 15, 2009, for U.S. Appl. No. 10/722,074, filed Nov. 24, 2003, 6 pages. |
Notice of Allowance dated Mar. 2, 2016, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 12 pages. |
Notice of Allowance dated Mar. 28, 2005, for U.S. Appl. No. 10/347,620, filed Jan. 22, 2003, 6 pages. |
Notice of Allowance dated May 3, 2011, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 12 pages. |
Spielman, A. et al. (2001). Mosquito: A Natural History of Our Most Persistent and Deadly Foe, First Edition, Hyperion, New York, NY, 3 pages. (Table of Contents Only). |
Sonntag, O. (1993). Ektachem. Dry Chemistry, Analysis With Carrier-Bound Reagents, Elsevier Science Publishers, 57 pages. |
Straub F.B. (Mar., 1939). “Isolation and Properties of a flavoprotien from Heart Muscle Tissue”, Biochemical Journal 33: 787-792. |
Tietz, N.W. (1986). Textbook of Clinical Chemistry, W.B. Saunders Company, pp. 1533 and 1556. |
U.S. Precision Lens, Inc. (1983).The Handbook of Plastic Optics. |
Written Opinion dated May 2, 2007, for PCT Application No. PCT/US2006/37923, filed on Sep. 9, 2006, 5 pages. |
Written Opinion dated Dec. 3, 2004, for PCT Application No. PCT/US2004/08798, filed on Mar. 24, 2004, 4 pages. |
Written Opinion dated Aug. 17, 2007 for PCT/US2006/38049, filed on Sep. 29, 2006, 6 pages. |
Written Opinion dated Aug. 16, 2007 for PCT Application No. PCT/US2006/038163, filed on Sep. 29, 2006, 4 pages. |
Written Opinion dated Oct. 19, 2012 for PCT Application No. PCT/US2012/049629, filed on Aug. 3, 2012, 7 pages. |
Written Opinion of the International Searching Authority dated Mar. 3, 2008, for PCT Application No. PCT/US2007/018780, filed on Aug. 27, 2007, 7 pages. |
Number | Date | Country | |
---|---|---|---|
20100010374 A1 | Jan 2010 | US |
Number | Date | Country | |
---|---|---|---|
61129025 | May 2008 | US |